Table 3.
Polyp name | Alternative terminology | Morphology and significance | Predominant location | Molecular features |
Hyperplastic polyp, goblet type | Type 1 hyperplastic polyp | Subtype of hyperplastic polyp with conspicuous goblet cells and showing the least morphologic deviation from normal; Described as goblet-cell rich type | Distal colon: Sigmoid and rectum | Frequent KRAS mutation (54%) |
Hyperplastic polyp, microvesicular type | Type 2 hyperplastic polyp | Variant of hyperplastic polyp in which columnar cells have mucin-filled vesicles within the apical cytoplasm and goblet cells are relatively inconspicuous | Right colon and distal colon | Frequent BRAF mutation (76%) and CIMP (68%) |
Sesile serrated adenoma | Sessile serrated polyp; Serrated polyp with atypical proliferation | Advanced type of serrated polyp with abnormalities of architecture and proliferation but lacking the classic features of epithelial dysplasia (intraepithelial neoplasia) | Right colon | Frequent BRAF mutation (75%-82%) and CIMP (92%) |
Sessile serrated adenoma with cytological dysplasia | Mixed polyp | Rare serrated polyp that includes two separate components: Nondysplastic (usually SSA) and either traditional adenoma or serrated adenoma | Right and left colon | Frequent BRAF mutation, (89%) |
Serrated adenoma | Mixed hyperplastic adenomatous polyp; Atypical hyperplastic polyp; TSA | Relatively rare neoplastic polyp having a serrated architecture reminiscent of hyperplastic polyp but with unequivocal traditional adenomatous dysplasia; Comprises < 5% of serrated polyps | Left colon | Marked molecular heterogeneity; May have either KRAS or BRAF mutation |
SSA: Sessile serrated adenoma; TSA: Traditional serrated adenoma; CIMP: CpG island methylator phenotype.